Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: A prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 6, 1999, Pages 775-780

  Ducons J A ^a   Santolaria, S ^a   Guirao, R ^a   Ferrero, M ^a   Montoro, M ^a   Gomollon F ^b,c  

^a HOSPITAL SAN JORGE   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; UREASE;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; DIARRHEA; DRUG EFFICACY; ERADICATION THERAPY; ERYTHEMA; FEMALE; GLOSSITIS; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; REGRESSION ANALYSIS; TASTE DISORDER; TREATMENT FAILURE; XEROSTOMIA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PROSPECTIVE STUDIES;

EID: 0033067387     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00549.x     Document Type: Article

References (16)

1. 1 Current European concepts in the management of Helicobacter pylori infecion. The Maastricht Consensus Report. Gut 1997; 41; 8-13.
2. 2 Pipkin GA, Willimansn R, Wood JR. Review article: one-week clarithromycin triple-therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12: 823-37.
3. 3 Cohen MI. Epidemiology of drug resistance. Sci 1992; 257: 1050-5.
4. 4 Mégraud F, Doermann HP. Clinical relevance of resistant strains of Helicobacter pylori: a review of current data. Gut 1998; 43(Suppl. 1): S61-S65.
5. 5 Graham DY. Antibiotic Resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998; 115: 1272-7.
6. 6 Vakil N, Hahn B, McSorley D. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am J Gastroenterol 1998; 93: 1432-5.
7. 7 Glupczynski Y, Burette A, Lamy V, Garrino MG. Evolution of H. pylori primary resitance to antimicrobial agents in Belgium beween 1995 and 1998. Gut 1998; 43(Suppl. 2): A159(Abstract).
8. 8 Hachem CY, Clarridge JE, Reddy R, et al. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin and metronidazole. Diagn Microbiol Infect Dis 1996; 24: 37-41.
9. 9 Moayyedi P, Ragunathan PL, Mapstone N, Axon AT, Tompkins DS. Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1998; 33: 160-3.
10. 10 Bazzoli F, Pozzato P, Zagari M, et al. Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis. Helicobacter 1998; 3: 195-201.
11. 11 Lamouliatte H, Cayla R. Helicobacter pylori eradication with one week triple therapy: meta-analysis of french studies. Gut 1998; 43(Suppl. 3): A287(Abstract).
12. 12 Broutet N, Guillon F, Sauty E, Lethuaire D, Mégraud F. Survey of the in vitro susceptibility of Helicobacter pylori to antibiotics in France. Preliminary reults. Gut 1998; 43(Suppl. 2): A28(Abstract).
13. 13 Spinzi GC, Bierti L, Bortoli A, et al. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 433-8.
14. 14 Comet R, Calvet X, Navarro M, García N, Sanfeliu I. Omeprazol, claritromicina y amoxicilina durante 7 días para el tratamiento de la infección por Helicobacter pylori. Eur J Gastroenterol Hepatol 1998; 21: 81-3.
15. 15 Calvet X, Cubells MJ, López-Lorente T, et al. Clarithromycin based dual and triple therapies for treatment of Helicobacter pylori infection in primary care: a multicenter, comparative, randomized trial. Gut 1998; 43(Suppl. 3); A321(Abstract).
16. 16 Fennerty MB, Kovacs TO, Krause R, et al. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Arch Intern Med 1998; 158: 1651-6.